Androgen Deprivation Therapy and High Dose Radiation Therapy With or Without Whole-Pelvic Radiation Therapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation
therapy may stop the adrenal glands from making androgens. Radiation therapy uses
high-energy x-rays to kill tumour cells.
PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation
therapy in treating patients with prostate cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society